Mirikizumab Inj 300 Mg/15 Ml Vial Reform 43624-0026
Product NDC
43624-0026- Manufacturer
- Bsp Pharmaceuticals S.p.a.
- Dosage Form
- Injection
- Product Type
- Drug For Further Processing
- Marketing Start
- October 26, 2023
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Mirikizumab | 300 mg/15mL |
Packaging Options(1)
121 VIAL, SINGLE-DOSE in 1 TRAY (43624-026-01) / 15 mL in 1 VIAL, SINGLE-DOSE